Recruiting NA Subacromial Impingement Syndrome

Compares treatment options for Subacromial Impingement Syndrome

Official title Virtual Reality Based Exercise Training Versus Mulligan Mobilization on Shoulder Posture and Function in Subacromial Impingement Syndrome

ClinicalTrials.gov ID: NCT07369934

What this study is testing

What it's testing
The study will compare the effect of virtual reality based exercise training versus Mulligan mobilization in addition to exercise therapy added to both groups on shoulder posture and function in subacromial impingement syndrome.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 30 to 50

You may be able to join if

  • Patients will be referred from the orthopedic surgeon with a diagnosis of stage II SIS with the following criteria:
  • Participants ranged in age from 30-50 years old.
  • Participants are from non-athletes from the general population.
  • Unilateral shoulder pain that is localized either anteriorly or laterally to the acromion. Pain that occurs or worsens when the affected shoulder is...
  • Four of the following should be present in the included patients: Neer impingement test, Hawkins' test, Pain was replicated in the supraspinatus...

You likely can't join if

  • 1) Patients who, during the previous three months, underwent shoulder physical treatment and/or an acute pain flare.
  • 2) Patients who have undergone surgeries for tendon repair. 3) Malignancy, epilepsy, pregnant women, and/or systemic conditions like chronic renal or...
  • 4) Mini-Mental State Examination test (MMSE) (\< 24/30) to exclude cognitive impairment and/or significant vision impairment (if they couldn't read...
  • 5) Corticosteroid injection during the last three months or used steroids chronically.
  • 6) Adhesive capsulitis, glenohumeral joint instability, Numbness or tingling of the upper limb, and/or full-thickness tear of the rotator cuff.
See the full eligibility criteria
Who can join
  • Patients will be referred from the orthopedic surgeon with a diagnosis of stage II SIS with the following criteria:
  • Participants ranged in age from 30-50 years old.
  • Participants are from non-athletes from the general population.
  • Unilateral shoulder pain that is localized either anteriorly or laterally to the acromion. Pain that occurs or worsens when the affected shoulder is in flexion and/or abduction.
  • Four of the following should be present in the included patients: Neer impingement test, Hawkins' test, Pain was replicated in the supraspinatus empty-can test, a painful arc of movement from 70° to 120°, and painful...
  • BMI range 18.5- 29.9 Kg/m².
What rules you out
  • 1) Patients who, during the previous three months, underwent shoulder physical treatment and/or an acute pain flare.
  • 2) Patients who have undergone surgeries for tendon repair. 3) Malignancy, epilepsy, pregnant women, and/or systemic conditions like chronic renal or liver failure.
  • 4) Mini-Mental State Examination test (MMSE) (\< 24/30) to exclude cognitive impairment and/or significant vision impairment (if they couldn't read the introduction while wearing the Head Mounted Device (HMD).
  • 5) Corticosteroid injection during the last three months or used steroids chronically.
  • 6) Adhesive capsulitis, glenohumeral joint instability, Numbness or tingling of the upper limb, and/or full-thickness tear of the rotator cuff.

The study team makes the final eligibility decision.

Where it's taking place

  • Giza, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 30 years to 50 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Giza, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.